Cambridge-based Biogen is looking to the growth of its Alzheimer’s drug Leqembi to offset the decline of its multiple ...

New drugs show promise, and research finds value in vaccines, antivirals, exercise and probiotics.

While social isolation is known to be an important factor in increasing the risk of dementia in old age, animal testing has ...

This research offers hope. By finding brain diseases earlier, we might be able to slow them down or manage them better. If ...

New research builds on evidence that diet, certain brain training exercises and physical activity can delay the decline of memory and other cognitive abilities.

In a major new finding almost a decade in the making, researchers at Harvard Medical School say they’ve found a key that may ...

In a provocative new study, Harvard Medical School scientists found that lithium, an element found in some foods and drinking ...

This is the moment to spend more money on research, not less. Right now, all over the world, researchers are collecting data about Alzheimer’s disease.

NIH funding for research on Alzheimer’s and other forms of dementia has risen from $562 million in 2014 to $3.9 billion in 2024.